Temporal immune effects of Oral ketamine on PTSD: Transcriptomic evidence of short-term inflammation suppression and sustained immune Remodelling
Open Access
- 30 November 2025
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 395 (Pt B) , 120791
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSDPsychopharmacology, 2025
- Chronic psychosocial stress triggers microglial‐/macrophage‐induced inflammatory responses leading to neuronal dysfunction and depressive‐related behaviorGlia, 2023
- Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depressionPsychopharmacology, 2021
- The emergence of ketamine as a novel treatment for posttraumatic stress disorder2020
- Ketamine Alleviates Fear Generalization Through GluN2B-BDNF Signaling in MiceNeuroscience Bulletin, 2019
- Augmenting the Treatment of PTSD with Ketamine—a ReviewCurrent Treatment Options in Psychiatry, 2019
- Subanesthetic Dose Ketamine in Posttraumatic Stress Disorder: A Role for Reconsolidation During Trauma-Focused Psychotherapy?2018
- Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended ReleaseArchives of General Psychiatry, 2006
- Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophagesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1997
- [44] Human neutrophil degranulation1988